CRTAM Polyclonal Antibody, APC-Cy5.5 Conjugated
Product Specifications
Background
Interaction with CADM1 promotes natural killer (NK) cell cytotoxicity and interferon-gamma (IFN-gamma) secretion by CD8+ cells in vitro as well as NK cell-mediated rejection of tumors expressing CADM3 in vivo.
Synonyms
CD355; Cytotoxic and regulatory T-cell molecule; Class-I MHC-restricted T-cell-associated molecule; CRTAM
Gene ID
56253
Swiss Prot
O95727
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
31-130/393
Target
CRTAM
Clonality
Polyclonal
Isotype
IgG
Conjugation
APC-Cy5.5
Source
KLH conjugated synthetic peptide derived from human CRTAM
Applications
FCM, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
650nm/694nm
Concentration
1µg/µl
Dilution
FCM (1:20-100), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
56253
Predicted Cross Reactivity
Mouse, Rat, Pig, Rabbit
More Discoveries
Explore Other Products
Browse additional items from our catalog
YLAQ0061HO-01 48 Tests
Horse Japanese Encephalitis Virus IgM (JE-IgM) ELISA Kit
Sign In for Pricing
View Details 
YLAQ0061HO-02 96 Tests
Horse Japanese Encephalitis Virus IgM (JE-IgM) ELISA Kit
Sign In for Pricing
View Details 243138 200 µL
AGER (Advanced Glycosylation End Product-Specific Receptor, MGC22357, RAGE)
Sign In for Pricing
View Details 
